Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
   By Anjali Athavaley 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912;

React to this article
Latest news on ALLERGAN, INC.
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 ALLERGAN : SEC Labels Actavis Registration Statement for Pending Acquisition of ..
01/28DJSALIX PHARMACEUTICALS : to Restate 2013, Partial 2014 Results
01/26DJActavis Buys Auden Mckenzie, to Become Largest UK Generic Supplier
01/22 ALLERGAN : Lieff Cabraser Announces Class Action Litigation Against Allergan Inc..
01/22 ACTAVIS : and Valeant raise prospect of more pharma deals
01/21 ALLERGAN : Assigned Ornamental Design Patent
01/21 ALLERGAN : Actavis and Allergan Update on Early Halt to Hart-Scott-Rodino Waitin..
01/15 ALLERGAN : Actavis and Allergan Update on Early Halt to Hart-Scott-Rodino Waitin..
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes